Global Expression Vectors Market Size, Share, Growth, Trends, and Forecast (2024 - 2031)
Global Expression Vectors Market Scope: Historical Data (2021 – 2022), Base Year (2023), Forecast Period (2024 – 2031)
Market Segmentation: By Host Type (Bacterial Expression Vectors, Mammalian Expression Vectors, Insect Expression Vectors, Yeast Expression Vectors, and Other Expression Vectors), Application (Therapeutic Applications, Research Applications, and Industrial Applications), End-User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs), and Academic Research Institutes), and Region (North America, Europe, Asia Pacific, Latin America, Middle East, and Africa)
Market Overview
The Global Expression Vectors Market was valued at USD 350.0 million in 2023 and is expected to reach USD 537.2 million by 2031 while growing at a CAGR of 5.5% during the forecast period (2024-2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Market Dynamics
This section of the report will analyze various driving and restraining factors that are expected to have a significant impact on the global expression vectors market growth. Expression vectors, crucial in molecular biology and genetic engineering, are DNA molecules crafted to express specific genes in host organisms like bacteria, yeast, or mammalian cells. Their primary function is to facilitate the production of proteins encoded by the inserted genes.
Advancements in antibodies, vaccines, and therapeutic proteins are anticipated to drive the expression vectors market. Despite this, obstacles such as ethical and regulatory concerns, along with high development costs, may impede market expansion.
Furthermore, the global expression vectors industry will be analyzed through various tools including PESTLE analysis, and Porter’s analysis.
Segmentation – By Host Type Analysis
The Global Expression Vectors Market is segmented among Bacterial Expression Vectors, Mammalian Expression Vectors, Insect Expression Vectors, Yeast Expression Vectors, and Other Expression Vectors, based on Host Type. In 2023, Bacterial Expression Vectors accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Segmentation – By Application Analysis
The Global Expression Vectors Market is segmented among Therapeutic Applications, Research Applications, and Industrial Applications, based on Application. In 2023, Therapeutic Applications accounted for the majority of the market share*.
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Global Expression Vectors Market: Regional Analysis
Based on region, the market is divided into six regions including North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. In 2023, North America dominated the market with the highest market share, while Asia Pacific is expected to grow with the highest CAGR during the forecast period (2024 – 2031).
*Note: Graph is shown for illustrative purposes only; complete datasets will be provided in the full report
Competitive Landscape
Some of the key players operating in the market are Thermo Fisher Scientific, Inc., Promega Corporation, Sigma-Aldrich Corporation, Bio-Rad Laboratories, Agilent Technologies, New England Biolabs, Merck KGaA, QIAGEN, DNA2.0, and GenScript USA Inc.
Table of Contents:
1. Research Methodology and Market Scope
Research Methodology
Market Scope
2. Executive Summary
3. Global Expression Vectors Market Dynamics
Drivers
Restraints
Opportunity
4. Global Expression Vectors Industry Analysis
PEST Analysis
Porter's Five Force Analysis
Recent Deals Analysis
5. Global Expression Vectors Market Segmentation, By Host Type
Global Expression Vectors Market Share Analysis, By Host Type
Global Expression Vectors Market Growth Analysis, By Host Type
Global Expression Vectors Market Trends, By Host Type
o Bacterial Expression Vectors
o Mammalian Expression Vectors
o Insect Expression Vectors
o Yeast Expression Vectors
o Other Expression Vectors
6. Global Expression Vectors Market Segmentation, By Application
Global Expression Vectors Market Share Analysis, By Application
Global Expression Vectors Market Growth Analysis, By Application
Global Expression Vectors Market Trends, By Application
o Therapeutic Applications
o Research Applications
o Industrial Applications
7. Global Expression Vectors Market Segmentation, By End-User
Global Expression Vectors Market Share Analysis, By End-User
Global Expression Vectors Market Growth Analysis, By End-User
Global Expression Vectors Market Trends, By End-User
o Pharmaceutical and Biotechnology Companies
o Contract Research Organizations (CROs) and Contract Manufacturing Organizations (CMOs)
o Academic Research Institutes
8. Global Expression Vectors Market Segmentation, By Region
Global Expression Vectors Market Share Analysis, By Region
Global Expression Vectors Market Growth Analysis, By Region
Global Expression Vectors Market Trends, By Region
o North America
o Europe
o Asia Pacific
o Latin America
o Middle East
o Africa
9. Competitive Landscape
Thermo Fisher Scientific, Inc.*
o Company Overview
o Financial Performance
o Key Development/Strategies
o SWOT Analysis
Promega Corporation
Sigma-Aldrich Corporation
Bio-Rad Laboratories
Agilent Technologies
New England Biolabs
Merck KGaA
QIAGEN
DNA2.0
GenScript USA Inc.
*Similar analysis will be provided for each company listed above.
